Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers

Biological Psychiatry

Volumn 23, Issue 7, 1988, Pages 689-697

  Alfredsson, G ^a   Wiesel, F A ^a   Tylec, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; GLUTAMIC ACID; HOMOVANILLIC ACID; NORADRENALIN; SEROTONIN;

ADULT; CEREBROSPINAL FLUID; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN;

ADULT; BLOOD-BRAIN BARRIER; FEMALE; GLUTAMATES; GLUTAMIC ACID; GLYCOLS; HOMOVANILLIC ACID; HUMAN; HYDROXYINDOLEACETIC ACID; MALE; METHOXYHYDROXYPHENYLGLYCOL; REFERENCE VALUES; SUPPORT, NON-U.S. GOV'T;

EID: 0023872943     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(88)90052-2     Document Type: Article

References (31)

1. Rapid high performance liquid Chromatographie method for the assay of glutamine in human cerebrospinal fluid
2. Glutamate and glutamine in cerebrospinal fluid and serum from healthy volunteers—Analytical aspects
3. CPRS. The Comprehensive Psychopathological Rating Scale
4. Plasma amino acids in relation to cerebrospinal fluid monamine metabolites in schizophrenic patients and healthy controls
5. Antipsychotic drugs, neurotransmitters, and schizophrenia
6. In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence of l-glutamate
7. Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration
8. Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients
9. Glutamate: A neurotransmitter in mammalian brain
10. Amino acids in plasma and CSF and monoamine metabolites in CSF: Interrelationship in healthy subjects
11. Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as precursors for the synthesis of preferentially released glutamate
12. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics
13. Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 μl plasma
14. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
15. High performance liquid Chromatographie determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde
16. 14C)glutamate from dentate but not from CA1/CA3 slices of rat hippocampus
17. Serotonin inhibits the depolarization-evoked release of endogenous glutamate from rat cerebellar nerve endings
18. Glutamine metabolism of isolated rat hepatocytes
19. Regulation of amino acid availability to brain: Selective control mechanisms for glutamate
20. Free amino acids and related compounds in different regions of human brain
21. Menstrual cycle affects plasma HVA
22. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
23. Disorders of glutamate metabolism and neurological dysfunction
24. Gamma-aminobutyric acid in brain: Its formation from glutamic acid
25. Striatal glutamatergic function: Modifications following specific lesions
26. Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico-striatal terminals in vitro
27. Mass fragmentographic determination of 4-hydroxy-3-methoxyphenylglucos (HMPG) in urine, cerebrospinal fluid, plasma and tissues using a deuterium-labelled internal standard
28. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method
29. Alfa-adrenergic stimulation of glutamine metabolism in isolated rat hepatocytes
30. Glutamate, GABA and CNS disease: A review
31. Psychiatric morbidity within the family and steady-state levels of cerebrospinal fluid monoamine metabolites